Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 17, Issue 12, 2010, Pages 896-

  Grebely, J ^a   Matthews, G V ^a   Petoumenos, K ^a   Dore, G J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ANTIVIRAL THERAPY; DISEASE DURATION; DRUG RESPONSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; SCREENING; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C; HUMANS; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 78649305844     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01256.x     Document Type: Letter

References (4)

1. Corey KE, Mendez-Navarro J, Gorospe EC, Zheng H, Chung RT,. Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis. J Viral Hepat 2009; August 6 [Epub ahead of print].
2. Dore GJ, Hellard M, Matthews GV, et al. Effective treatment of injecting drug users with recently acquired Hepatitis C virus infectionEffective treatment of injecting drug users with recently acquired Hepatitis C virus infection. Gastroenterology 2009; September 24 [Epub ahead of print].
3. Grebely J, Petoumenos K, Matthews GV, et al. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: the ATAHC Study. Drug Alcohol Depend 2009; November 16 [Epub ahead of print].
4. Micallef JM, Kaldor JM, Dore GJ,. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13: 34 - 41.